Navigation Links
M. Scott Harris, M.D., Joins Ocera Therapeutics, Inc., as Chief Medical Officer
Date:2/27/2008

SAN DIEGO, Feb. 27 /PRNewswire/ -- Ocera Therapeutics, a biopharmaceutical company focused on the licensing, development and commercialization of proprietary compounds to treat a broad range of gastrointestinal and liver diseases, announced today that M. Scott Harris, M.D., has joined the company as Chief Medical Officer. Prior to joining Ocera, Dr. Harris held the position of Chief Medical Officer and Vice President of Clinical Affairs at Napo Pharmaceuticals. Dr. Harris has extensive experience in gastrointestinal diseases as well as clinical and regulatory operations.

"We are delighted by Scott's addition to our team and find his academic credentials, clinical practice treating patients suffering from Inflammatory Bowel Disease and his clinical development experience to be a great fit for Ocera," stated Laurent Fischer, M.D., co-founder, President and CEO of Ocera Therapeutics. "Scott brings a wealth of experience in the gastroenterology space, with a particular focus in Crohn's disease as well as practical expertise in all stages of drug development and commercialization."

"Adding Scott to the team comes at a key time for the company as we approach the results of our pivotal Phase 3 trial for Crohn's disease," commented Eckard Weber, M.D., partner at Domain Associates, co-founder of Ocera and chairman of the board. "We look forward to his added guidance and expertise in this pivotal stage of the company's growth."

Dr. Harris has served in several clinical development and medical affairs roles within the industry. He was a principal and vice president of pharmaceutical research and development at Middleburg Consultants where he served as a clinical and regulatory consultant to pharmaceutical companies. He also served as the global director of clinical development for Otsuka America. Dr. Harris held senior-level positions at Abbott Laboratories and Schwarz Pharma, Inc.

"Ocera is an excellent example of a company with a focused de
'/>"/>

SOURCE Ocera Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. L&M Healthcare Communications, LLC, Hires Scott Karasinski, PharmD
2. Genzyme and Isis Announce Hart-Scott-Rodino Approval of Collaboration
3. Anaptys Biosciences Appoints R. Scott Greer to Board of Directors
4. Expiry of Hart-Scott-Rodino Waiting Period for JUVISTA(R) (Human TGF BETA 3)
5. Hsiao Dee Lieu, M.D., F.A.C.C. Named VP of Clinical Research of Nile Therapeutics
6. BiPar Names Hoyoung Huh, M.D., Ph.D. President and Chief Executive Officer
7. Nektar Appoints Hoyoung Huh, M.D., Ph.D., to Serve on the Companys Board of Directors
8. Poniard Pharmaceuticals Appoints Robert De Jager, M.D., as Chief Medical Officer
9. Cynthia Haines, M.D., Named Managing Editor of Physicians Briefing News Wire
10. MacroChem Announces Michael Zasloff, M.D., Ph.D. Joins Companys Scientific Advisory Board
11. Royea Joins Eklin Medical Systems as VP of Worldwide Sales
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... January 22, 2015 GEA Niro Soavi ... top laboratory homogenizer, the PandaPLUS 2000, which is ideal ... , and cell disruption . This compact laboratory ... fruit juices, liquid food, food additives and ingredients as ...
(Date:1/22/2015)... 22, 2015 Crystal Diagnostics (CDx) Xpress System, ... has received AOAC-PTM Certifications for the six non-O157 Shiga toxin-producing ... collectively referred to as STEC or the “Big-6”) as well ... unit (cfu) per 325 g of raw ground beef and ...
(Date:1/22/2015)... 2015 Selexis SA, a serial innovation ... Banks (RCBs) used for drug discovery to commercial manufacturing, ... include Next-Generation Sequencing (NGS) data packages. The ... manufacturing by ensuring the integrity of the gene, validation ...
(Date:1/22/2015)... CAMBRIDGE, Mass. , Jan. 22, 2015   GenoSpace , ... suite of tools to enable the broad use of genomic, ... today announced the appointment of Michelle Munson , CEO ... independent director. Logo - http://photos.prnewswire.com/prnh/20150122/170713 ...
Breaking Biology Technology:GEA Niro Soavi Announces the PandaPLUS 2000 Homogenizer for Processing New Applications for Nanoemulsions and Cell Disruption 2Crystal Diagnostics Awarded AOAC-PTM Accreditation for the Rapid Detection of “Big 6” E.coli Food Pathogens 2Selexis Generated Research Cell Banks Now Fully Sequenced Using Next-Generation Sequencing 2GenoSpace Expands Board with Appointment of Michelle Munson 2
... , ... Group is pleased to announce that Dr. Michael Langley is joining the company as ... served many roles during his career with Lilly in both animal science and human ... led a number of successful regulatory engagements including both European and US regulatory submissions. ...
... , WINSTON-SALEM, N.C. , Jan. 29 ... They are the stars of a new animated film, "Cell Side ... in cooperation with Wake Forest University and other community ... and female animated characters that dramatize what happens within cells. ...
... Jan. 28 Tissue Genesis, Inc., an emerging leader ... Medical Systems Holdings, Inc. (Nasdaq: AMMD ) announced today ... of adipose (fat)–derived regenerative cells for use in treating pelvic ... over the life of the agreement to obtain rights ...
Cached Biology Technology:Michael Langley, DVM, MBA, RAC Joins the Anson Group as a Regulatory Consultant 2New Musical 'Cell Side Story' Puts Science on Stage 2New Musical 'Cell Side Story' Puts Science on Stage 3American Medical Systems and Tissue Genesis Sign $1.1 Million Collaboration Deal 2American Medical Systems and Tissue Genesis Sign $1.1 Million Collaboration Deal 3American Medical Systems and Tissue Genesis Sign $1.1 Million Collaboration Deal 4
(Date:12/17/2014)... Valencell, a leader in performance biometric data sensor technology, ... such as Intel, Jabra, Atlas, and Scosche to develop ... products will be showcased at CES 2015, taking place ... "Our partners choose PerformTek biometrics, because ...
(Date:12/11/2014)... , Dec. 09, 2014 Research and Markets ... ( http://www.researchandmarkets.com/research/9ql3kr/biometrics_market ) has announced the addition of the ... their offering. One major trend emerging ... systems. Multimodal biometric systems utilize more than one characteristic ...
(Date:12/10/2014)... Forest Baptist Medical Center today announced plans for a new ... this $50 million capital project is part of a larger ... The medical education building will be located in ... to 525@vine in Wake Forest Innovation Quarter. Construction will begin ...
Breaking Biology News(10 mins):Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2Biometrics Market in India 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 4
... the American Society of Tropical Medicine and Hygiene, the ... on research advances in the fight against diseases that ... in Central Florida, animal-borne diseases the world over and ... innovations to combat the global epidemic of counterfeit malaria ...
... developed a strain of the Middle East respiratory syndrome coronavirus ... disease, according to a study to be published in ... for Microbiology. The mutant MERS virus, rMERS-CoV-ΔE, has a mutation ... a cell and replicating its genetic material, but deprives it ...
... , Sept. 9, 2013 /PRNewswire-iReach/ -- BioForce Nanosciences, Inc. ... international network of partners and distributors. The partnership will help ... Europe , the Middle East ... Asia . BioForce specializes in nanometer-scale ...
Cached Biology News:American Society of Tropical Medicine and Hygiene 62nd Annual Meeting Nov. 13-17, Washington DC 2American Society of Tropical Medicine and Hygiene 62nd Annual Meeting Nov. 13-17, Washington DC 3Scientists engineer strain of MERS coronavirus for use in a vaccine 2Scientists engineer strain of MERS coronavirus for use in a vaccine 3BioForce Nanosciences, Inc. Expands Its Global Market. New partnership with Acugenex Limited 2
... 1,4-Dithiothreitol DTT ... Purity: ≥99% by titration. ... (100 mM, 1 cm, 260 nm): ≤0.500; ... Heavy metals: ≤0.001%. Soluble ...
... Basically, most ``special`` dye stains are ... few other non-routine) stains are $9.00. ... a paraffin block, staining, coverslipping and ... (for senile plaques) ,Bodian`s Stain ,Copper ...
... Dithiothreitol DTT White solid.. PACKAGED ... to thiols, so reaction is "driven" to completion. ... contain waxy surfactant found in many other preparations. ... Purity: ≥97% by titration. Contaminants: ...
... This kit is designed for easy ... The protocol allows for successful transformation simply ... kit reagents with cultured yeast cells. No ... washing, are required. The kit is particularly ...
Biology Products: